Pexidartinib is a receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3, with potential antineoplastic activity, with IC50 of 28 and 16 nM for Fms and Kit, respectively.
IC50 & Target: IC50: 28 nM (c-Fms), 16 nM (c-Kit)
In Vivo: Pexidartinib is a potent drug for treatment of cancer and used for Phase III TGCT clinical trial[1].
Protocol:
References:
Gelhorn HL, et al. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors. Clin Ther. 2016 Apr;38(4):778-93.
Tags:Pexidartinib supplier,Pexidartinib purchase,Pexidartinib manufacturer,Pexidartinib sigma,Pexidartinib distributor,cost,Pexidartinib buy,Pexidartinib for sale